Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71751 - 71775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	MYBL1	4603	upregulated	Silicon Dioxide analog results in increased expression of MYBL1 mRNA	8q13.1	A24195
Silicon dioxide	Approved	MYC	4609	upregulated	Silicon Dioxide analog results in increased expression of MYC mRNA	8q24.21	A24195
Silicon dioxide	Approved	MYC	4609	upregulated	Silicon Dioxide results in increased expression of MYC mRNA	8q24.21	A24198
Silicon dioxide	Approved	MYCBP	26292	downregulated	Silicon Dioxide analog results in decreased expression of MYCBP mRNA	1p34.3	A24195
Silicon dioxide	Approved	MYCL	4610	downregulated	Silicon Dioxide results in decreased expression of MYCL mRNA	1p34.2	A24196
Silicon dioxide	Approved	MYEOV	26579	upregulated	Silicon Dioxide analog results in increased expression of MYEOV mRNA	11q13.3	A24195
Silicon dioxide	Approved	MYH11	4629	upregulated	Silicon Dioxide analog results in increased expression of MYH11 mRNA	16p13.11	A24194
Silicon dioxide	Approved	MYH2	4620	downregulated	Silicon Dioxide analog results in decreased expression of MYH2 mRNA	17p13.1	A24195
Silicon dioxide	Approved	MYH3	4621	upregulated	Silicon Dioxide analog results in increased expression of MYH3 mRNA	17p13.1	A24195
Silicon dioxide	Approved	MYL9	10398	upregulated	Silicon Dioxide analog results in increased expression of MYL9 mRNA	20q11.23	A24195
Silicon dioxide	Approved	MYLK	4638	downregulated	Silicon Dioxide results in decreased expression of MYLK mRNA	3q21.1	A24196
Silicon dioxide	Approved	MYO18A	399687	downregulated	Silicon Dioxide analog results in decreased expression of MYO18A mRNA	17q11.2	A24195
Silicon dioxide	Approved	MYO19	80179	downregulated	Silicon Dioxide results in decreased expression of MYO19 mRNA	17q12	A24196
Silicon dioxide	Approved	MYO1A	4640	downregulated	Silicon Dioxide analog results in decreased expression of MYO1A mRNA	12q13.3	A24195
Silicon dioxide	Approved	MYO1D	4642	downregulated	Silicon Dioxide analog results in decreased expression of MYO1D mRNA	17q11.2	A24195
Silicon dioxide	Approved	MYO5C	55930	downregulated	Silicon Dioxide results in decreased expression of MYO5C mRNA	15q21.2	A24196
Silicon dioxide	Approved	MYOF	26509	upregulated	Silicon Dioxide analog results in increased expression of MYOF mRNA	10q23.33	A24195
Silicon dioxide	Approved	MYOM3	127294	upregulated	Silicon Dioxide analog results in increased expression of MYOM3 mRNA	1p36.11	A24194
Silicon dioxide	Approved	MYPN	84665	upregulated	Silicon Dioxide analog results in increased expression of MYPN mRNA	10q21.3	A24195
Silicon dioxide	Approved	MYRF	745	downregulated	Silicon Dioxide analog results in decreased expression of MYRF mRNA	11q12.2	A24195
Silicon dioxide	Approved	MZB1	51237	downregulated	Silicon Dioxide analog results in decreased expression of MZB1 mRNA	5q31.2	A24195
Silicon dioxide	Approved	MZT2A	653784	upregulated	Silicon Dioxide analog results in increased expression of MZT2A mRNA	2q21.1	A24195
Silicon dioxide	Approved	N4BP2L1	90634	upregulated	Silicon Dioxide analog results in increased expression of N4BP2L1 mRNA	13q13.1	A24194
Silicon dioxide	Approved	N4BP2L1	90634	downregulated	Silicon Dioxide results in decreased expression of N4BP2L1 mRNA	13q13.1	A24196
Silicon dioxide	Approved	N4BP2L2	10443	downregulated	Silicon Dioxide results in decreased expression of N4BP2L2 mRNA	13q13.1	A24196

Displaying entries 71751 - 71775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability